Detalhe da pesquisa
1.
Virtual multi-institutional tumor board: a strategy for personalized diagnoses and management of rare CNS tumors.
J Neurooncol
; 167(2): 349-359, 2024 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-38427131
2.
Phase II study of border zone stereotactic radiosurgery with bevacizumab in patients with recurrent or progressive glioblastoma multiforme.
J Neurooncol
; 164(1): 179-190, 2023 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-37515669
3.
Immune checkpoint inhibitor therapy for recurrent meningiomas: a retrospective chart review.
J Neurooncol
; 157(2): 271-276, 2022 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-35301639
4.
Cutaneous metastasis of primary diffuse large B-cell lymphoma of the central nervous system developing 4 years after complete remission: Diagnosis confirmed by comparison of clones.
J Cutan Pathol
; 49(1): 90-94, 2022 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-34498750
5.
The effects of SmartCare© on neuro-oncology family caregivers' distress: a randomized controlled trial.
Support Care Cancer
; 30(3): 2059-2068, 2022 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-34655326
6.
Safety of Direct Oral Anticoagulants in Central Nervous System Malignancies.
Oncologist
; 26(5): 427-432, 2021 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-33523555
7.
Pemetrexed in Recurrent or Progressive Central Nervous System Lymphoma: A Phase I Multicenter Clinical Trial.
Oncologist
; 25(9): 747-e1273, 2020 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-32520407
8.
Retrospective study of nivolumab for patients with recurrent high grade gliomas.
J Neurooncol
; 139(3): 625-631, 2018 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-29779086
9.
Phase I study of sorafenib and tipifarnib for recurrent glioblastoma: NABTC 05-02.
J Neurooncol
; 136(1): 79-86, 2018 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-28988377
10.
Rindopepimut with temozolomide for patients with newly diagnosed, EGFRvIII-expressing glioblastoma (ACT IV): a randomised, double-blind, international phase 3 trial.
Lancet Oncol
; 18(10): 1373-1385, 2017 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-28844499
11.
Family caregivers' level of mastery predicts survival of patients with glioblastoma: A preliminary report.
Cancer
; 123(5): 832-840, 2017 03 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-27787881
12.
Neuro-oncology family caregivers' view on keeping track of care issues using eHealth systems: it's a question of time.
J Neurooncol
; 134(1): 157-167, 2017 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-28550505
13.
Phase I trial of aflibercept (VEGF trap) with radiation therapy and concomitant and adjuvant temozolomide in patients with high-grade gliomas.
J Neurooncol
; 132(1): 181-188, 2017 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-28116649
14.
Correction to: The effects of SmartCare© on neurooncology family caregivers' distress: a randomized controlled trial.
Support Care Cancer
; 30(8): 7041, 2022 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-35606480
15.
Short-T2 imaging for quantifying concentration of sodium (23 Na) of bi-exponential T2 relaxation.
Magn Reson Med
; 74(1): 162-174, 2015 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-25078966
16.
Multicenter phase 1 trial of intraventricular immunochemotherapy in recurrent CNS lymphoma.
Blood
; 121(5): 745-51, 2013 Jan 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-23197589
17.
Phase 2 study of CT-322, a targeted biologic inhibitor of VEGFR-2 based on a domain of human fibronectin, in recurrent glioblastoma.
Invest New Drugs
; 33(1): 247-53, 2015 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-25388940
18.
Vandetanib plus sirolimus in adults with recurrent glioblastoma: results of a phase I and dose expansion cohort study.
J Neurooncol
; 121(3): 627-34, 2015 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-25503302
19.
AZD2171, a pan-VEGF receptor tyrosine kinase inhibitor, normalizes tumor vasculature and alleviates edema in glioblastoma patients.
Cancer Cell
; 11(1): 83-95, 2007 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-17222792
20.
Evaluating the Base Excision Repair Inhibitor TRC102 and Temozolomide for patients with Recurrent Glioblastoma in the Phase 2 Adult Brain Tumor Consortium Trial BERT.
Clin Cancer Res
; 2024 Jun 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-38836759